☰

Richard C. Zink, Ph.D. - Publications

Affiliations: 
2003 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Biostatistics Biology
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Zink RC, Castro-Schilo L, Ding J. Understanding the influence of individual variables contributing to multivariate outliers in assessments of data quality. Pharmaceutical Statistics. PMID 30259643 DOI: 10.1002/Pst.1903  0.361
2018 Zink RC, Dmitrienko A, Dmitrienko A. Rethinking the Clinically Based Thresholds of TransCelerate BioPharma for Risk-Based Monitoring. Therapeutic Innovation & Regulatory Science. 2168479017738981. PMID 29714565 DOI: 10.1177/2168479017738981  0.323
2018 Zink RC, Marchenko O, Sanchez-Kam M, Ma H, Jiang Q. Sources of Safety Data and Statistical Strategies for Design and Analysis: Clinical Trials. Therapeutic Innovation & Regulatory Science. 52: 141-158. PMID 29714519 DOI: 10.1177/2168479017738980  0.335
2018 Marchenko O, Russek-Cohen E, Levenson M, Zink RC, Krukas-Hampel MR, Jiang Q. Sources of Safety Data and Statistical Strategies for Design and Analysis: Real World Insights. Therapeutic Innovation & Regulatory Science. 52: 170-186. PMID 29714518 DOI: 10.1177/2168479017739270  0.33
2018 Zink RC. Introduction to the Special Section for Sources of Safety Data and Statistical Strategies for Design and Analysis. Therapeutic Innovation & Regulatory Science. 52: 140. PMID 29714517 DOI: 10.1177/2168479018760813  0.309
2017 Marchenko O, Jiang Q, Chuang-Stein C, Mehta C, Levenson M, Russek-Cohen E, Liu L, Sanchez-Kam M, Zink R, Ke C, Ma H, Maca J, Park S. Statistical Considerations for Cardiovascular Outcome Trials in Patients with Type 2 Diabetes Mellitus Statistics in Biopharmaceutical Research. 9: 347-360. DOI: 10.1080/19466315.2017.1280411  0.314
2014 By K, Qaqish BF, Preisser JS, Perin J, Zink RC. ORTH: R and SAS software for regression models of correlated binary data based on orthogonalized residuals and alternating logistic regressions. Computer Methods and Programs in Biomedicine. 113: 557-68. PMID 24286728 DOI: 10.1016/J.Cmpb.2013.09.017  0.536
2013 Zink RC, Huang Q, Zhang LY, Bao WJ. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance. Chinese Journal of Natural Medicines. 11: 314-20. PMID 23725848 DOI: 10.1016/S1875-5364(13)60035-7  0.305
2013 Zink RC, Wolfinger RD, Mann G. Summarizing the incidence of adverse events using volcano plots and time intervals. Clinical Trials (London, England). 10: 398-406. PMID 23690094 DOI: 10.1177/1740774513485311  0.307
2012 Qaqish BF, Zink RC, Preisser JS. Orthogonalized residuals for estimation of marginally specified association parameters in multivariate binary data. Scandinavian Journal of Statistics, Theory and Applications. 39: 515-527. PMID 23180903 DOI: 10.1111/J.1467-9469.2012.00802.X  0.587
2012 Zink RC, Koch GG. NParCov3: ASAS/IMLMacro for Nonparametric Randomization-Based Analysis of Covariance Journal of Statistical Software. 50. DOI: 10.18637/Jss.V050.I03  0.381
2012 Zink RC, Mann G. On the Importance of a Single Data Standard Drug Information Journal. 46: 362-367. DOI: 10.1177/0092861512441101  0.328
Show low-probability matches.